• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性心包积液:病理生理学与临床关联

Malignant pericardial effusions: pathophysiology and clinical correlates.

作者信息

Mangan C M

机构信息

Northwestern Memorial Hospital, Chicago, IL.

出版信息

Oncol Nurs Forum. 1992 Sep;19(8):1215-21.

PMID:1408962
Abstract

Cardiac tamponade resulting from malignant pericardial effusions is a life-threatening oncologic emergency. As many as 21% of all patients with cancer may be at risk for this complication. A malignant effusion often signifies progressing disease, creating stress and anxiety for patients and their families. By understanding the pathophysiology and pertinent risk factors, the nurse may identify an effusion before it progresses to cardiac tamponade. The goal of management is removal of fluid, restoration of hemodynamic functioning, and prevention of fluid reaccumulation. Emotional support and reassurance, as well as accurate information regarding the disease and treatment, also are critical in assisting patients to adapt to these changes in disease status.

摘要

恶性心包积液导致的心包填塞是一种危及生命的肿瘤急症。所有癌症患者中多达21%可能有发生这种并发症的风险。恶性积液往往意味着疾病进展,给患者及其家人带来压力和焦虑。通过了解病理生理学和相关风险因素,护士可以在积液进展为心包填塞之前识别出来。治疗的目标是清除液体、恢复血流动力学功能并防止液体再次积聚。情感支持和安慰,以及关于疾病和治疗的准确信息,对于帮助患者适应疾病状态的这些变化也至关重要。

相似文献

1
Malignant pericardial effusions: pathophysiology and clinical correlates.恶性心包积液:病理生理学与临床关联
Oncol Nurs Forum. 1992 Sep;19(8):1215-21.
2
Pericardial tamponade: an oncologic emergency.
Clin J Oncol Nurs. 1998 Jul;2(3):85-95.
3
Pericardial effusion with tamponade: relief for the symptomatic patient.心包积液伴心脏压塞:症状性患者的缓解方法。
Dimens Oncol Nurs. 1988 Fall;2(3):18-20.
4
Primary percutaneous balloon pericardiotomy for malignant pericardial effusion.原发性经皮球囊心包切开术治疗恶性心包积液
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):504-7. doi: 10.1002/ccd.21431.
5
[Treatment of malignant pericardial effusion].[恶性心包积液的治疗]
Gan To Kagaku Ryoho. 2008 Jun;35(6):906-9.
6
Pericardial effusion and tamponade: evaluation, imaging modalities, and management.心包积液与心包填塞:评估、影像学检查方法及处理
Compr Ther. 1995 Jul;21(7):378-85.
7
Subxiphoid partial pericardiectomy with or without sclerosant instillation in the treatment of symptomatic pericardial effusions in patients with malignancy.剑突下心包部分切除术联合或不联合硬化剂注射治疗恶性肿瘤患者的症状性心包积液
Cancer. 1991 Sep 1;68(5):1021-5. doi: 10.1002/1097-0142(19910901)68:5<1021::aid-cncr2820680519>3.0.co;2-6.
8
Canine pericardial effusion: pathophysiology and cause.犬心包积液:病理生理学与病因
Compend Contin Educ Vet. 2007 Jul;29(7):400-3; quiz 404.
9
Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions.心包穿刺术和心包内硬化术:治疗恶性心包积液的有效方法。
Ann Thorac Surg. 1997 Nov;64(5):1422-7; discussion 1427-8. doi: 10.1016/S0003-4975(97)00992-2.
10
[Cardiac tamponade as clinical manifestation of neoplastic process: presentation of 11 cases and review of the literature].[肿瘤性疾病的临床表现——心脏压塞:11例病例报告及文献复习]
An Med Interna. 2000 Jan;17(1):25-8.